Circle Wealth Management LLC Takes $425,000 Position in Humana Inc. $HUM

Circle Wealth Management LLC bought a new stake in Humana Inc. (NYSE:HUM) in the first quarter, HoldingsChannel reports. The firm bought 1,607 shares of the insurance provider’s stock, valued at approximately $425,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Cary Street Partners Investment Advisory LLC lifted its stake in shares of Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares during the period. Riverview Trust Co purchased a new position in shares of Humana in the 1st quarter valued at approximately $34,000. Garde Capital Inc. purchased a new position in shares of Humana in the 1st quarter valued at approximately $36,000. Zions Bancorporation National Association UT purchased a new position in Humana during the first quarter valued at $37,000. Finally, Whipplewood Advisors LLC raised its stake in Humana by 639.1% during the first quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider’s stock valued at $45,000 after buying an additional 147 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Up 1.9%

Humana stock opened at $300.0120 on Friday. The firm has a market cap of $36.08 billion, a price-to-earnings ratio of 23.02, a PEG ratio of 1.73 and a beta of 0.44. The stock has a fifty day simple moving average of $248.58 and a two-hundred day simple moving average of $253.73. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $382.72. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the previous year, the business posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana’s dividend payout ratio (DPR) is presently 27.17%.

Analysts Set New Price Targets

A number of research analysts have issued reports on HUM shares. Wall Street Zen cut Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Piper Sandler lowered their price objective on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research note on Thursday, July 31st. Wells Fargo & Company lowered their price objective on Humana from $348.00 to $344.00 and set an “overweight” rating for the company in a research note on Thursday, August 14th. Bank of America lowered their price objective on Humana from $320.00 to $260.00 and set a “neutral” rating for the company in a research note on Tuesday, June 17th. Finally, Morgan Stanley lowered their price objective on Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research note on Thursday, July 31st. Seven analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $283.29.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.